These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 31688595)

  • 1. Investigation of Fluorodeoxyglucose Positron Emission Tomography for the Diagnosis of Solid Pseudopapillary Neoplasm of the Pancreas: A Study Associated With a National Survey of Solid Pseudopapillary Neoplasms.
    Kurihara K; Hanada K; Serikawa M; Ishii Y; Tsuboi T; Kawamura R; Sekitou T; Nakamura S; Mori T; Hirano T; Ikemoto J; Chayama K
    Pancreas; 2019; 48(10):1312-1320. PubMed ID: 31688595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperaccumulation of (18)F-FDG in order to differentiate solid pseudopapillary tumors from adenocarcinomas and from neuroendocrine pancreatic tumors and review of the literature.
    Guan ZW; Xu BX; Wang RM; Sun L; Tian JH
    Hell J Nucl Med; 2013; 16(2):97-102. PubMed ID: 23687644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 18F-fluorodeoxyglucose positron emission tomography/computed tomography and the relationship between fluorodeoxyglucose uptake and the expression of hypoxia-inducible factor-1α, glucose transporter-1 and vascular endothelial growth factor in thymic epithelial tumours.
    Toba H; Kondo K; Sadohara Y; Otsuka H; Morimoto M; Kajiura K; Nakagawa Y; Yoshida M; Kawakami Y; Takizawa H; Kenzaki K; Sakiyama S; Bando Y; Tangoku A
    Eur J Cardiothorac Surg; 2013 Aug; 44(2):e105-12. PubMed ID: 23674658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical correlations with (18)FDG PET scan patterns in solid pseudopapillary tumors of the pancreas: still a surgical enigma?
    Kang CM; Cho A; Kim H; Chung YE; Hwang HK; Choi SH; Lee WJ
    Pancreatology; 2014; 14(6):515-23. PubMed ID: 25256437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maximum standardized uptake value on 18F-fluoro-2-deoxy-glucose positron emission tomography/computed tomography and glucose transporter-1 expression correlates with survival in invasive ductal carcinoma of the pancreas.
    Kitasato Y; Yasunaga M; Okuda K; Kinoshita H; Tanaka H; Okabe Y; Kawahara A; Kage M; Kaida H; Ishibashi M
    Pancreas; 2014 Oct; 43(7):1060-5. PubMed ID: 25121413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of a solid pseudopapillary tumor of the pancreas with F-18 FDG positron emission tomography.
    Lee JK; Tyan YS
    Clin Nucl Med; 2005 Mar; 30(3):187-8. PubMed ID: 15722825
    [No Abstract]   [Full Text] [Related]  

  • 7. TFE3 is a diagnostic marker for solid pseudopapillary neoplasms of the pancreas.
    Jiang Y; Xie J; Wang B; Mu Y; Liu P
    Hum Pathol; 2018 Nov; 81():166-175. PubMed ID: 30030118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of F-18-FDG PET/CT findings between pancreatic solid pseudopapillary tumor and pancreatic ductal adenocarcinoma.
    Kim YI; Kim SK; Paeng JC; Lee HY
    Eur J Radiol; 2014 Jan; 83(1):231-5. PubMed ID: 24290142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in the characterization of pancreatic masses: experience from tropics.
    Santhosh S; Mittal BR; Bhasin D; Srinivasan R; Rana S; Das A; Nada R; Bhattacharya A; Gupta R; Kapoor R
    J Gastroenterol Hepatol; 2013 Feb; 28(2):255-61. PubMed ID: 23278193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. F-18 fluorodeoxyglucose uptake in a solid pseudopapillary tumor of the pancreas mimicking malignancy.
    Shimada K; Nakamoto Y; Isoda H; Maetani Y; Yamashita R; Arizono S; Hirokawa Y; Nitta T; Doi R; Haga H; Togashi K
    Clin Nucl Med; 2008 Nov; 33(11):766-8. PubMed ID: 18936608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SUVmax of FDG-PET correlates with the effects of neoadjuvant chemoradiotherapy for oral squamous cell carcinoma.
    Miyawaki A; Ikeda R; Hijioka H; Ishida T; Ushiyama M; Nozoe E; Nakamura N
    Oncol Rep; 2010 May; 23(5):1205-12. PubMed ID: 20372831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The usefulness of lymphoid enhancer-binding factor 1 and androgen receptor in diagnosing solid pseudopapillary neoplasm of the pancreas on cytopathology.
    McHugh KE; Stelow EB; Harrison GP; Policarpio-Nicolas MLC
    Cancer Cytopathol; 2019 Nov; 127(11):700-707. PubMed ID: 31584754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography in differential diagnosis of benign and malignant intraductal papillary-mucinous neoplasm of the pancreas.
    Tomimaru Y; Takeda Y; Tatsumi M; Kim T; Kobayashi S; Marubashi S; Eguchi H; Tanemura M; Kitagawa T; Nagano H; Umeshita K; Wakasa K; Doki Y; Mori M
    Oncol Rep; 2010 Sep; 24(3):613-20. PubMed ID: 20664965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical role of fludeoxyglucose (18F) positron emission tomography/computed tomography (
    Matsumoto T; Okabe H; Yamashita YI; Yusa T; Itoyama R; Nakao Y; Yamao T; Umzaki N; Tsukamoto M; Kitano Y; Miyata T; Arima K; Nitta H; Hayashi H; Imai K; Chikamoto A; Baba H
    Surg Today; 2019 Jan; 49(1):21-26. PubMed ID: 30128759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical utility of 2-[(18)F] fluoro-2-deoxy-D-glucose positron emission tomography in predicting World Health Organization grade in pancreatic neuroendocrine tumors.
    Tomimaru Y; Eguchi H; Tatsumi M; Kim T; Hama N; Wada H; Kawamoto K; Kobayashi S; Morii E; Mori M; Doki Y; Nagano H
    Surgery; 2015 Feb; 157(2):269-76. PubMed ID: 25311263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of cytomorphology in distinguishing solid pseudopapillary neoplasm of pancreas from pancreatic neuroendocrine tumor with emphasis on nuclear folds and nuclear grooves.
    Misra S; Saran RK; Srivastava S; Barman S; Dahale A
    Diagn Cytopathol; 2019 Jun; 47(6):531-540. PubMed ID: 30677247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FDG PET/CT findings of solid pseudopapillary tumor of the pancreas with CT and MRI correlation.
    Dong A; Wang Y; Dong H; Zhang J; Cheng C; Zuo C
    Clin Nucl Med; 2013 Mar; 38(3):e118-24. PubMed ID: 23354028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of preoperative fluorodeoxyglucose positron emission tomography/computed tomography in patients with potentially resectable pancreatic cancer.
    Omiya Y; Ichikawa S; Satoh Y; Motosugi U; Nakajima N; Onishi H
    Abdom Radiol (NY); 2018 Dec; 43(12):3381-3389. PubMed ID: 30043215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contrast-enhanced fluorodeoxyglucose positron emission tomography/computed tomography in solid pseudopapillary neoplasm of the pancreas.
    Santhosh S; Lakshmanan RK; Sonik B; Padmavathy R; Gunaseelan RE
    Indian J Nucl Med; 2016; 31(2):131-3. PubMed ID: 27095862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Solid-pseudopapillary neoplasm of the pancreas: awareness of unusual clinical presentations and morphology of the clear cell variant can prevent diagnostic errors.
    Zhao P; deBrito P; Ozdemirli M; Sidawy MK
    Diagn Cytopathol; 2013 Oct; 41(10):889-95. PubMed ID: 23584981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.